# Neural Biomarkers in Fragile X Syndrome

> **NCT06957054** · — · COMPLETED · sponsor: **Connecta Therapeutics, S.L.** · enrollment: 20 (actual)

## Conditions studied

- Fragile X Syndrome (FXS)
- Neurotypical Adults

## Interventions

- **OTHER:** Any

## Key facts

- **NCT ID:** NCT06957054
- **Lead sponsor:** Connecta Therapeutics, S.L.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-12-16
- **Primary completion:** 2025-03-20
- **Final completion:** 2025-03-20
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-05-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06957054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06957054, "Neural Biomarkers in Fragile X Syndrome". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06957054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*